AACR press release

News Date: 
02 March 2017

Trace is involved in one of the latest press releases of the The American Association for Cancer Research (AACR) about the publication of Cuppens T et al: "Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative."

The potential therapeutic value of the most promising target, p-S6S240, was tested in patient-derived xenograft (PDX) leiomyosarcoma models. The PDX experiments were conducted at Trace, the KULeuven PDX platform.

Read the press release here. 


Trace PDX models

Search in our online database to find a relevant model that fits into your research pipeline. For more advice, contact us